Search

everythinglearnresearchcommunity

for

Search:↓

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Some medications can help increase sexual desire and function in women.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Public interest in finasteride's sexual side effects has significantly increased.

There is a significant need for better-validated quality of life tools in dermatology.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Hair loss in women linked to higher sexual dysfunction risk.

Finasteride is considered the best treatment for hair loss, despite side effects.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Men with lower education levels are more likely to have erectile dysfunction if they have coronary artery disease.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Finasteride does not negatively affect male reproductive function.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.